Your privacy is important to us. Cookies are very small text files that are stored on your computer when you visit a website. We use cookies and other tracking technologies for a variety of purposes and to enhance your online experience on our website. You can change your preferences and decline certain types of cookies to be stored on your computer while browsing our website. You can also remove any cookies already stored on your computer, but keep in mind that deleting cookies may prevent you from using parts of our website. You can check our privacy policy page for more information.
Today, there are nearly 1,181 medicines in development for prevention of chronic diseases. A new report from PhRMA explores these medicines that target these diseases and conditions.
-
ReportToday, there are more than 280 vaccines in development by biopharmaceutical research companies for the treatment or prevention of disease. Explore the new report from PhRMA about vaccines in development.
-
ReportToday, there are 1,600 treatments and vaccines in development for cancer. Explore the new report from PhRMA examining these innovative medicines.
-
ReportToday, there are more than 400 medicines in development for leading chronic diseases affecting older Americans. A new report from PhRMA explores the medicines that target these diseases and conditions.
-
ReportRead more about the full list of more than 180 medicines treating the many diseases and conditions of particular concern to mental health.
-
ReportToday, there are nearly 800 medicines in development for chronic diseases. A new report from PhRMA explores these medicines that target these diseases and conditions.
-
ReportRead about the more than 500 medicines, treating many of the diseases and conditions that affect the blood, that are currently in development by the America's biopharmaceutical research companies.
-
ReportRead about the more than 600 medicines and vaccines, treating many of the diseases and conditions of particular concern for women's health, that are currently in development by the America's biopharmaceutical research companies.
-
ReportRead about the more than 700 medicines and vaccines, treating many of the approximately 8,000 known rare diseases, that are currently in development by the America's biopharmaceutical research companies.
-
ReportToday, more than 260 medicines and vaccines for 29 different neurodegenerative diseases are currently in development by innovative biopharmaceutical research companies.
-
ReportToday, more than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities.
-
ReportAs the world confronts the COVID-19 public health crisis, now more than ever is the time to consider preparedness for a growing public health threat: antimicrobial resistance (AMR). This means a robust and sustained pipeline of new and novel antimicrobial medicines is critical to ensure that new innovations and interventions can keep pace with these evolving pathogens.
-
ReportMore than 400 medicines and vaccines are in development to tackle infectious diseases.
-
ReportOver the years, vaccines have played a critical role in reducing the spread of, and, in some cases, eliminating the threat of the world’s many devastating infectious diseases. Vaccines represent some of the most impactful public health advances seen to date.
-
ReportNearly 400 cell and gene therapies are in development, targeting a broad range of diseases.
-
ReportThe biopharmaceutical industry is currently developing nearly 600 medicines to meed the unique needs of pediatric patients.
-
ReportBiopharmaceutical companies are developing more than 160 new treatments for diabetes, including some that would offer an oral medicine option for Type 1 diabetes patients who currently administer insulin daily.
-
ReportThere are nearly 20 medicines in development for Sickle Cell Disease, including gene therapies.
-
ReportThere are more than 100 medicines in development for Asthma, respiratory allergies, and other breathing diseases.
-
ReportMore than 300 medicines to treat skin diseases are in development by biopharmaceutical research companies.
-
ReportAmerica’s biopharmaceutical research companies are developing 200 medicines for leading causes of death in the U.S.
-
ReportAmerica's biopharmaceutical companies are developing 537 medicines for numerous, wide-ranging neurological disorders.
-
ReportAmerica’s biopharmaceutical research companies are investigating or developing 85 medicines for Alzheimer's.
-
ReportAmerica’s biopharmaceutical research companies are developing 52 medicines and vaccines for HIV.
-
ReportAmerica’s biopharmaceutical research companies are developing more than 240 immuno-oncology treatments.
-
ReportAmerica’s biopharmaceutical research companies are investigating or developing 80 medicines for autoimmune diseases.
-
ReportAmerica's biopharmaceutical research companies are developing nine medicines for the treatment of osteoporosis.
-
ReportAmerica’s biopharmaceutical research companies are developing more than 240 medicines for leukemia, lymphoma and other blood cancers.
-
ReportAmerica’s biopharmaceutical research companies are currently developing 37 medicines to help the estimated 1.5 million Americans living with Parkinson’s Disease.
-
ReportAmerica’s biopharmaceutical research companies are developing 907 biologics targeting more than 100 diseases.
-
ReportAmerica’s biopharmaceutical research companies are working on 54 medicines to treat chronic obstructive pulmonary disease (COPD).
The Inflation Reduction Act puts patients’ access to medicines on the line.
-
LEARN MOREThis website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.